Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease

NCT02817997 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02817997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02817997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACCELERATE (Advancing Castleman Care With an Electronic Longitudinal Registry, E-Repository, And Treatment/Effectiveness Research): An International Registry for Patients With Castleman Disease
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2016
Completion date
September 30, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiofollicular lymph hyperplasia, angiofollicular lymph node hyperplasia, angiofollicular lymphoid hyperplasia, castleman disease, castleman's disease, giant lymph node hyperplasia, glnh, hyperplasia, giant lymph node, lymph node hyperplasia, giant